Similarly, it has been demonstrated to improve osteoarthritis by inhibiting the secretion of matrix metallopeptidase 13 (MMP-13) through the relative expression of the nuclear factor kappa-B ligand (RANKL)/osteoprotegerin (OPG) ratio [62]. This evidence concerns the gene TNFRSF11B and osteoarthritis.